TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01602016 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT00923884 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00923884 — Predictive Biomarker (PRD): CYP1B1 mRNA
Genes: CYP1B1
Study NCT00923884 — Predictive Biomarker (PRD): CYP19A1 mRNA
Genes: CYP19A1; ARO1; CYAR; CYP19
Study NCT03397017 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03288493 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01679743 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00241683 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01590069 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00521274 — Predictive Biomarker (PRD): TPBG mRNA
Genes: TPBG; 5T4
Study NCT02447926 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02447926 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT00706992 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03560921 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01913756 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01913756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03665948 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04867421 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02854059 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT03236454 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02425215 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04085471 — Predictive Biomarker (PRD): CTHRC1 mRNA
Genes: CTHRC1; UNQ762/PRO1550
Study NCT03939520 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02443545 — Predictive Biomarker (PRD): Liver iron
Study NCT02924376 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT04346264 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02158897 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT01565538 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01565538 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00764179 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01854814 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01670656 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT03134456 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02356991 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02356991 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02356991 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT02841176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02593227 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02593227 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT01418716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00847106 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT04418375 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04418375 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT00393120 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00393120 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02917746 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02858648 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01211899 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT00254371 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04557176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03927443 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT02232750 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study NCT00280878 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): VGF mRNA
Genes: VGF
Study NCT00263614 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02980302 — Predictive Biomarker (PRD): MYT1L mRNA
Genes: MYT1L; KIAA1106
Study NCT02032251 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT00734201 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01544036 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00286403 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00004402 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03030716 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03415984 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03415984 — Predictive Biomarker (PRD): FFAR2 mRNA
Genes: FFAR2; FFA2; GPCR43; GPR43
Study NCT03680287 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT02286219 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02122718 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01791153 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02851550 — Predictive Biomarker (PRD): LIPA mRNA
Genes: LIPA
Study NCT02093221 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT03018379 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01715896 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03870945 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03507413 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT03507413 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03507413 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03857256 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04194684 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02206373 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01000493 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00618137 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT00893477 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04072276 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01093534 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT01613950 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01613950 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01613950 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03250299 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03336957 — Safety Biomarker (SAF): Interleukin 1
Study NCT03580291 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02046668 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study NCT03534024 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03534024 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT02035020 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT02035020 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00049842 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT01701037 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT00654784 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02777515 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03277131 — Surrogate Endpoint (SUR): Bacterial count
Study NCT03907800 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00325832 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01626963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01626963 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03070392 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02709486 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT02930291 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02930291 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02581878 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01102569 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01102569 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00314405 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT03783455 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT03783455 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05752565 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00288717 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03603938 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01083017 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05495373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02804555 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00316069 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02736617 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04332016 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00949455 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00949455 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02682355 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02360345 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00507611 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT02504346 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02504346 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03693196 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT03693196 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT01045421 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT02575612 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03421756 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04027374 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study NCT01229644 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT04415008 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study NCT04118114 — Predictive Biomarker (PRD): PTP4A3 mRNA
Genes: PTP4A3; PRL3
Study NCT03217409 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00086554 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study NCT03267420 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02818387 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00569413 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT00772720 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT04653311 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT03379012 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03065595 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00965055 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00003743 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03621007 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study NCT03621007 — Predictive Biomarker (PRD): PCSK1 mRNA
Genes: PCSK1; NEC1
Study NCT03664661 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT03158493 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04209335 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT02462655 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT02462655 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04715997 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00081809 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT00750126 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04226235 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03342599 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01692314 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01625130 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT02466789 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02562482 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02252653 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02030314 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02999282 — Predictive Biomarker (PRD): GRN mRNA
Genes: GRN
Study NCT03993964 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03993964 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01904006 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04126213 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02151721 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02151721 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03720340 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT03433755 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04293549 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT03329079 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02599376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02516410 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02516410 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT00996931 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01404871 — Predictive Biomarker (PRD): SLC1A1 mRNA
Genes: SLC1A1; EAAC1; EAAT3; HEAAC1
Study NCT01404871 — Predictive Biomarker (PRD): GRIN2B mRNA
Genes: GRIN2B; NMDAR2B
Study NCT01404871 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04594174 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03477656 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT02939014 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02480218 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02480218 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00437463 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00703508 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT02893995 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04367805 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02060409 — Predictive Biomarker (PRD): U2AF1 mRNA
Genes: U2AF1; U2AF35; U2AFBP; FP793
Study NCT02060409 — Predictive Biomarker (PRD): ZRSR2 mRNA
Genes: ZRSR2; U2AF1-RS2; U2AF1L2; U2AF1RS2; URP
Study NCT02596386 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00832221 — Safety Biomarker (SAF): DRD2
Study NCT00829270 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT02896608 — Predictive Biomarker (PRD): HCN1 mRNA
Genes: HCN1; BCNG1
Study NCT05017844 — Predictive Biomarker (PRD): KSR1 mRNA
Genes: KSR1; KSR
Study NCT00764634 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03779646 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03779646 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01940497 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03043560 — Predictive Biomarker (PRD): KCNQ2 mRNA
Genes: KCNQ2
Study NCT00749281 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02987959 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01643512 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01294826 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00430950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01281761 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01918631 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02963402 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study NCT02429037 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01049620 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01049620 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT03937349 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03937349 — Surrogate Endpoint (SUR): Serum calcium
Study NCT06451393 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03357887 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03357887 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04546893 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04069546 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03642353 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06196021 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04729647 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04729647 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT04254835 — Surrogate Endpoint (SUR): Bacterial count
Study NCT02598258 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04724434 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00398931 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01092078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02276079 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02276079 — Safety Biomarker (SAF): BDNF
Study NCT03863483 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02396784 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01828944 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01717430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01566864 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03332797 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03332797 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03332797 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03061955 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02011750 — Predictive Biomarker (PRD): TOX mRNA
Genes: TOX; KIAA0808
Study NCT02011750 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT02011750 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT03795831 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04019184 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT03864042 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT03864042 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03084237 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03508687 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02867657 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02357342 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02225665 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00831636 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03733873 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01304693 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03648034 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03648034 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00865514 — Predictive Biomarker (PRD): GSTZ1 mRNA
Genes: GSTZ1; MAAI
Study NCT02824471 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02593513 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03766490 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00356980 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01259115 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03335852 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03335852 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03201406 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00116519 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00116519 — Predictive Biomarker (PRD): TG mRNA
Genes: TG